<scp>FGF11</scp> regulated by <scp>CTBP1‐AS2</scp> / <scp>miR</scp> ‐520a‐5p/ <scp>miR</scp> ‐432‐5p axis inhibits the progression and angiogenesis in high glucose‐treated human microvascular endothelial cells

Authors

Institutions

Publication Details

Journal
Journal of Diabetes Investigation
Published
2025-12-12
DOI
https://doi.org/10.1111/jdi.13990
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FGF11 regulated by CTBP1‐AS2 / miR ‐520a‐5p/ miR ‐432‐5p axis inhibits the progression and angiogenesis in high glucose‐treated human microvascular endothelial cells

T. Zhang, Ying Liu, Bo Chen, Zhongjie Ji
Journal of Diabetes Investigation
Fibroblast Growth Factor Research
article

FGF11 regulated by CTBP1‐AS2 / miR ‐520a‐5p/ miR ‐432‐5p axis inhibits the progression and angiogenesis in high glucose‐treated human microvascular endothelial cells

T. Zhang, Ying Liu, Bo Chen, Zhongjie Ji
article en

Abstract

No abstract available for this paper.
Journal of Diabetes Investigation
Harbin Medical University (CN), Second Affiliated Hospital of Harbin Medical University (CN)
Openalex Percentile: Top 64%
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.